B

Broncus Holding Corp
HKEX:2216

Watchlist Manager
Broncus Holding Corp
HKEX:2216
Watchlist
Price: 2.37 HKD 0.42%
Market Cap: 1.2B HKD

Broncus Holding Corp
Investor Relations

Broncus Holding Corp. engages in provision of interventional diagnosis and therapeutics solutions. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-09-24. The firm's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.

Show more
Loading
2216
Hang Seng (Hong Kong)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Hong Xu
Chairman of the Board & CEO
No Bio Available
Ms. Elaine Lu
Director of Finance & Administration
No Bio Available
Thomas M. Keast
VP, Operation Director & Scientist in resident
No Bio Available
Feng Yao
Sr. Accountant
No Bio Available
Ms. Ka Yan Suen
Company Secretary
No Bio Available

Contacts

Address
ZHEJIANG
Hangzhou
Room 801, 8/F, Building 8, No. 88 Jiangling Road, Xixing Street, Binjiang District
Contacts